Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
C-Met targeted fluorescence molecular endoscopy in Barrett's esophagus patients and identification of outcome parameters for phase-I studies.
de Jongh SJ, Voskuil FJ, Schmidt I, Karrenbeld A, Kats-Ugurlu G, Meersma GJ, Westerhof J, Witjes MJH, van Dam GM, Robinson DJ, Nagengast WB. de Jongh SJ, et al. Among authors: van dam gm. Theranostics. 2020 Apr 6;10(12):5357-5367. doi: 10.7150/thno.42224. eCollection 2020. Theranostics. 2020. PMID: 32373217 Free PMC article.
Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.
Terwisscha van Scheltinga AG, van Dam GM, Nagengast WB, Ntziachristos V, Hollema H, Herek JL, Schröder CP, Kosterink JG, Lub-de Hoog MN, de Vries EG. Terwisscha van Scheltinga AG, et al. Among authors: van dam gm. J Nucl Med. 2011 Nov;52(11):1778-85. doi: 10.2967/jnumed.111.092833. Epub 2011 Oct 11. J Nucl Med. 2011. PMID: 21990576 Free article.
Towards clinically translatable NIR fluorescence molecular guidance for colonoscopy.
Garcia-Allende PB, Glatz J, Koch M, Tjalma JJ, Hartmans E, Terwisscha van Scheltinga AG, Symvoulidis P, van Dam GM, Nagengast WB, Ntziachristos V. Garcia-Allende PB, et al. Among authors: van dam gm. Biomed Opt Express. 2013 Dec 4;5(1):78-92. doi: 10.1364/BOE.5.000078. eCollection 2013 Dec 4. Biomed Opt Express. 2013. PMID: 24466478 Free PMC article.
A standardized light-emitting diode device for photoimmunotherapy.
de Boer E, Warram JM, Hartmans E, Bremer PJ, Bijl B, Crane LM, Nagengast WB, Rosenthal EL, van Dam GM. de Boer E, et al. Among authors: van dam gm. J Nucl Med. 2014 Nov;55(11):1893-8. doi: 10.2967/jnumed.114.142299. Epub 2014 Oct 14. J Nucl Med. 2014. PMID: 25315245 Free article.
Optical innovations in surgery.
de Boer E, Harlaar NJ, Taruttis A, Nagengast WB, Rosenthal EL, Ntziachristos V, van Dam GM. de Boer E, et al. Among authors: van dam gm. Br J Surg. 2015 Jan;102(2):e56-72. doi: 10.1002/bjs.9713. Br J Surg. 2015. PMID: 25627136 Review.
Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp Detection.
Tjalma JJ, Garcia-Allende PB, Hartmans E, Terwisscha van Scheltinga AG, Boersma-van Ek W, Glatz J, Koch M, van Herwaarden YJ, Bisseling TM, Nagtegaal ID, Timmer-Bosscha H, Koornstra JJ, Karrenbeld A, Kleibeuker JH, van Dam GM, Ntziachristos V, Nagengast WB. Tjalma JJ, et al. Among authors: van herwaarden yj, van dam gm. J Nucl Med. 2016 Mar;57(3):480-5. doi: 10.2967/jnumed.115.166975. Epub 2015 Dec 17. J Nucl Med. 2016. PMID: 26678613 Free article.
Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer.
Koch M, de Jong JS, Glatz J, Symvoulidis P, Lamberts LE, Adams AL, Kranendonk ME, Terwisscha van Scheltinga AG, Aichler M, Jansen L, de Vries J, Lub-de Hooge MN, Schröder CP, Jorritsma-Smit A, Linssen MD, de Boer E, van der Vegt B, Nagengast WB, Elias SG, Oliveira S, Witkamp AJ, Mali WP, Van der Wall E, Garcia-Allende PB, van Diest PJ, de Vries EG, Walch A, van Dam GM, Ntziachristos V. Koch M, et al. Among authors: van der wall e, van diest pj, van dam gm, van der vegt b. Cancer Res. 2017 Feb 1;77(3):623-631. doi: 10.1158/0008-5472.CAN-16-1773. Epub 2016 Nov 22. Cancer Res. 2017. PMID: 27879266
Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study.
Lamberts LE, Koch M, de Jong JS, Adams ALL, Glatz J, Kranendonk MEG, Terwisscha van Scheltinga AGT, Jansen L, de Vries J, Lub-de Hooge MN, Schröder CP, Jorritsma-Smit A, Linssen MD, de Boer E, van der Vegt B, Nagengast WB, Elias SG, Oliveira S, Witkamp AJ, Mali WPTM, Van der Wall E, van Diest PJ, de Vries EGE, Ntziachristos V, van Dam GM. Lamberts LE, et al. Among authors: van der wall e, van diest pj, van dam gm, van der vegt b. Clin Cancer Res. 2017 Jun 1;23(11):2730-2741. doi: 10.1158/1078-0432.CCR-16-0437. Epub 2016 Nov 9. Clin Cancer Res. 2017. PMID: 28119364 Clinical Trial.
Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets.
Hartmans E, Orian-Rousseau V, Matzke-Ogi A, Karrenbeld A, de Groot DJ, de Jong S, van Dam GM, Fehrmann RS, Nagengast WB. Hartmans E, et al. Among authors: van dam gm. Theranostics. 2017 Jan 6;7(2):482-492. doi: 10.7150/thno.16816. eCollection 2017. Theranostics. 2017. PMID: 28255344 Free PMC article.
205 results